LEVETIRACETAM DEXCEL 250

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

LEVETIRACETAM

可用日期:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC代码:

N03AX14

药物剂型:

TABLETS

组成:

LEVETIRACETAM 250 MG

给药途径:

PER OS

处方类型:

Required

厂商:

DEXCEL LTD, ISRAEL

治疗组:

LEVETIRACETAM

治疗领域:

LEVETIRACETAM

疗效迹象:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

授权日期:

2018-03-31